JELINDA CHERRY STOKES: Open Payments
NPI 1811452360 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 60 payments from 13 companies in 2025. Trend: 2023 $494 · 2024 $875 · 2025 $1,123
Food & beverage: $1,123
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $257 |
| ABBVIE INC. | 27 | $240 |
| Otsuka America Pharmaceutical, Inc. | 3 | $154 |
| Bausch Health US, LLC | 6 | $132 |
| Alkermes, Inc. | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $79 |
| Lundbeck LLC | 3 | $57 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
| Almatica Pharma LLC | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, REXULTI, APLENZIN, TRINTELLIX, LYBALVI, ARISTADA, INGREZZA.
Industry payments across SC — which companies pay providers there.
